17 completed, 10 recruiting, 8 unknown, 5 active not recruiting. 20 Not applicable, 14 Phase 2, 6 Phase 1, 6 Phase 3, 2 Phase 4.
Follow Cystoscopy: new trials by email Literature Review of Cystoscopy trials Research Report on Cystoscopy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Home-Based Outpatient Model for BCG Delivery to Reduce Undue Burden on Patients Undergoing Treatment for Non-Muscle Invasive Bladder Carcinoma BCG Solution, Best Practice, Cystoscopy - Non-Muscle Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 49 | 2027-01-15 | 2026-10-14 |
| Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Radiosensitizing Agent - Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | University of Washington | 12 | 2026-08-20 | 2026-08-25 |
| Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial Biospecimen Collection, Computed Tomography, Cystoscopy - Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 111 | 2025-11-25 | 2026-11-03 |
| Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed? investigation setting (cystoscopy + CTU + cytology), Cystoscopy - CTU - cytology (if needed) - Hematuria, Acute Cystitis With Hematuria | Recruiting | Vastra Gotaland Region | 300 | 2025-10-13 | 2025-11-21 | |
| Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer utDNA testing + Urine Cytology, Cystoscopy + Urine Cytology - Bladder Cancer, Liquid Biopsy | Not applicable | Active not recruiting | Tianjin Medical University Second Hospital | 360 | 2025-09-20 | 2026-09-28 |
| Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy BCG Solution, Biopsy of Bladder, Cystoscopy - Recurrent Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 330 | 2025-07-17 | 2026-10-02 |
| In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial BCG Solution, Cystoscopy, Docetaxel - Non-Muscle Invasive Bladder Carcinoma, Stage 0a Bladder Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 40 | 2025-04-21 | 2026-10-08 |
| Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer Enfortumab Vedotin, Pembrolizumab, Intensity Modulated Radiation Therapy (IMRT) - Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 47 | 2025-03-31 | 2026-10-01 |
| Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia Diagnostic procedures, Flexible Cystoscopy - Cystoscopic Surgical Procedures, Pain | Not applicable | Enrolling by invitation | Marmara University | 120 | 2025-03-01 | 2025-04-27 |
| A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. Cystoscopy with RedPine flexible disposable cystoscope, Cystoscopy with standard of care flexible reusable scope - Bladder Cancer, Bladder Stone | Not applicable | Withdrawn | Guangzhou Red Pine Medical Instrument Co., Ltd. | 2024-10-01 | 2025-04-04 | |
| Evaluation of the Water Vapor Thermal Therapy System for the Treatment of Benign Prostatic Hyperplasia Water Vapor Thermal Ablation, Cystoscopy - Benign Prostatic Hyperplasia | Not applicable | Recruiting | Medtecx Co Ltd. | 126 | 2024-03-26 | 2024-12-17 |
| Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study Biospecimen Collection, cfDNA or ctDNA Measurement, Computed Tomography - Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma | Phase 2 / Phase 3 | Recruiting | National Cancer Institute (NCI) | 992 | 2024-02-02 | 2026-11-12 |
| Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test - Non-muscle-invasive Bladder Cancer | Phase 2 | Recruiting | White River Junction Veterans Affairs Medical Center | 240 | 2023-11-17 | 2026-09-16 |
| Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC) CxBladder Monitor, Cystoscopy - Non-muscle Invasive Bladder Cancer | Completed | Mayo Clinic | 107 | 2023-11-16 | 2026-01-23 | |
| Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial Atezolizumab, Biospecimen Collection, Computed Tomography - Bladder Carcinoma, Bladder Urothelial Carcinoma | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2023-10-12 | 2025-10-21 | |
| ICG for Visualization of the Ureters in DIE Ureteral injection of Indocyanine Green Powder (diluted) - Visualization of Ureters in Gynecological Surgery, Deep Infiltrative Endometriosis | Not applicable | Completed | Insel Gruppe AG, University Hospital Bern | 51 | 2023-06-26 | 2026-06-17 |
| MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer MRI-Guided Transurethral Ultrasound Ablation, Questionnaire Administration, Digital Rectal Examination - Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 | Not applicable | Recruiting | Mayo Clinic | 100 | 2022-04-06 | 2026-07-22 |
| Mapping 3D Bladder Cystoscopy - Bladder Cancer | Withdrawn | University Health Network, Toronto | 2022-03-01 | 2022-04-14 | ||
| Pain Outcomes During Rigid Cystoscopy in Females With and Without Cystoscopic Sheath Obturator Cystoscopy - with use of obturator sheath, Cystoscopy - without use of obturator sheath - Dysuria | Not applicable | Terminated | Todd Moyerbrailean DO FACOG | 68 | 2021-12-22 | 2022-04-07 |
| A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial Biopsy of Bladder, Biospecimen Collection, Cisplatin - Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 11 | 2021-03-17 | 2026-05-22 |
Showing 20 of 50. Sign in to see all of them.
Urinary Bladder Neoplasms (24) · Non-Muscle Invasive Bladder Neoplasms (6) · Prostatic Hyperplasia (5) · Hematuria (4) · Cystitis, Interstitial (3) · Pain (3) · Carcinoma in Situ (2) · Carcinoma, Transitional Cell (2) · Lower Urinary Tract Symptoms (2) · Urinary Bladder, Overactive (2) · Urinary Tract Infections (2) · Anxiety Disorders (1) · Cystitis (1) · Disease (1) · Dysuria (1)
National Cancer Institute (NCI) (8) · Mayo Clinic (3) · Medway NHS Foundation Trust (3) · Mansoura University (2) · AdventHealth (1) · Alliance for Clinical Trials in Oncology (1) · AnchorDx Medical Co., Ltd. (1) · Boston Scientific Corporation (1) · Guangzhou Red Pine Medical Instrument Co., Ltd. (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · ICOS Corporation (1) · Insel Gruppe AG, University Hospital Bern (1) · Institut du Cancer de Montpellier - Val d'Aurelle (1) · Kafrelsheikh University (1) · Marmara University (1)
United States (31) · Canada (5) · China (3) · Egypt (3) · Turkey (Türkiye) (3) · Guam (2) · United Kingdom (2) · Australia (1) · France (1) · Puerto Rico (1) · Russia (1) · Sweden (1) · Switzerland (1)
Claus Roehrborn, MD (2) · Adrian S Ishkanian, MD (1) · Ahmed Mosbah, MD (1) · Amr A Elsawy (1) · Andrea B Apolo (1) · Cheryl T Lee, MD (1) · David A Woodrum, MD, PhD (1) · David Azria, MD, PhD (1) · Di Maria Jiang (1) · Eugene Pietzak, MD (1) · Florian R Schroeck, MD, MS (1) · Franziska Siegenthaler, PD (1) · Hassan Abol-Enein, MD (1) · Haydar Kamil Cam, Professor Doctor (1)
PMID 11857671, PMID 17002859, PMID 17419703, PMID 22818539, PMID 23636866, PMID 32734597, PMID 39282902, PMID 42821609
U10CA180821 (3), U10CA180888 (2), P30CA006973 (1), R37CA275916 (1), U01CA084968 (1), U10CA180820 (1), UL1TR002377 (1), UM1CA186644 (1)